An epitope-focused nanoparticle vaccine for anthrax

Ended Project Grant Awarded Last action

Award ID
R44AI142939
Recipient
Awarding agency
Obligated
$4,249,237

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date
Originally
Funding
  • $3,265,538.79 Federal
  • $983,698.00 Non-federal
Place of performance
California, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment -$2 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $983,698 $0
Amendment $983,698 $983,698
Amendment $998,145 $0
Original award $300,000 $0
Show all 11

Quick answers

Who received award R44AI142939?

R44AI142939 was awarded to VLP Biotech, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on May 1, 2019.

How much is award R44AI142939 worth?

$4,249,237 has been obligated on R44AI142939: $3,265,539 in federal funding and $983,698 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award